MedTrace Logo

A Pharmacokinetic Comparison of Three Butyrate Products

NCT06700785 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-11-22

No results posted yet for this study

Summary

This study is a randomized, three-arm, interventional study of N=10 apparently healthy men. This study will quantify plasma butyrate responses to a single dose of three different butyrate products.

Conditions

  • Gastro-Intestinal Disorder

Interventions

DIETARY_SUPPLEMENT

Lysine butyrate

Lysine butyrate supplement. This study will compare plasma pharmacokinetic profiles of three commercially available butyrate supplements.

DIETARY_SUPPLEMENT

Sodium Butyrate

Oral sodium butyrate supplement.

DIETARY_SUPPLEMENT

Tributyrin

Oral tributyrin supplement.

Sponsors & Collaborators

  • The Center for Applied Health Sciences, LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-03
Primary Completion
2024-07-16
Completion
2024-09-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06700785 on ClinicalTrials.gov